IL-6 and IGF-1 Signaling Within and Between Muscle and Bone: How Important is the mTOR Pathway for Bone Metabolism? Astrid D. BakkerRichard T. Jaspers Osteocytes (T Bellido and J Klein-Nulend, Section Editors) Open access 25 February 2015 Pages: 131 - 139
Chemotherapy- and Irradiation-Induced Bone Loss in Adults with Solid Tumors Michel D. Wissing Osteoporosis and Cancer (P Clezardin and G van der Pluijm, Section Editors) Open access 25 February 2015 Pages: 140 - 145
GNAS Spectrum of Disorders Serap TuranMurat Bastepe Rare Bone Disease (CB Langman and E Shore, Section Editors) 08 April 2015 Pages: 146 - 158
Sclerostin and CKD-MBD Susan C. Schiavi Kidney and Bone (SM Moe and IB Salusky, Section Editors) 19 February 2015 Pages: 159 - 165
Bone Imaging and Fracture Risk Assessment in Kidney Disease Sophie A. JamalThomas L. Nickolas Kidney and Bone (SM Moe and IB Salusky, Section Editors) 06 March 2015 Pages: 166 - 172
Bone is Not Alone: the Effects of Skeletal Muscle Dysfunction in Chronic Kidney Disease Keith G. AvinRanjani N. Moorthi Kidney and Bone (SM Moe and IB Salusky, Section Editors) 19 February 2015 Pages: 173 - 179
An Overview of the Metabolic Functions of Osteocalcin Jianwen WeiGerard Karsenty Bone and Diabetes (AV Schwartz and P Vestergaard, Section Editors) 26 March 2015 Pages: 180 - 185
Bone Cells and Bone Turnover in Diabetes Mellitus Mishaela R. Rubin Bone and Diabetes (AV Schwartz and P Vestergaard, Section Editors) 06 March 2015 Pages: 186 - 191